Juniper
Subang Jaya Medical Centre (SJMC) bagged the coveted title of ‘Malaysia’s Hospital Company of the Year’ at the recently held virtual 2021 Frost & Sullivan Asia Pacific Best Practices Awards.
SJMC, part of the Ramsay Sime Darby Health Care Group, is being recognised for its excellence in three areas which Frost & Sullivan deems as “imperatives” in the digital health industry: Transformative Mega Trends, Disruptive Technologies, and Innovative Business Models.
Trish Hogan, Chief Executive Officer of SJMC, said, “Celebrating our 36th year in healthcare, the prestigious Frost & Sullivan award is testament to our years of being a trailblazer with multiple firsts in the industry and a deep commitment to exemplary cancer care and high patient care standards. As part of Ramsay Sime Darby Health Care, SJMC’s dedicated team of doctors and staff will remain steadfast in serving the community by working through challenging circumstances to provide excellent healthcare services both locally and internationally.”
Among SJMC’s achievements is the launch of next-generation sequencing to enable targeted cancer therapies. The hospital also launched telehealth services for patients amid the Covid-19 pandemic to give online consultations and support sessions, including speech therapists and clinical psychologists. Additionally, the hospital has the Joint Commission International accreditation and certification, which is recognised as a global standard for superior quality of healthcare and patient safety.
Honouring exceptional industry leaders for the past 19 years, the Frost & Sullivan Asia Pacific Best Practices Awards aim to recognise industries practising visionary innovation, outstanding customer care and world class performance. The company undertakes an extensive evaluation process in selecting winners for each award category.
Siddharth Shah, Research Manager, Healthcare and Life Sciences of Frost & Sullivan added, “SJMC continues to be a trailblazer with many firsts in Malaysia’s hospital industry, the latest being the launch of next-generation sequencing to enable targeted cancer therapies. In facilitating personalized medicine, SJMC not only offers personalized care for cancer patients but also supports treatment with state-of-the-art technologies, such as advanced imaging equipment and digital surgery solutions. It focuses on providing premium healthcare services, such as robotic rehabilitation services. SJMC also launched telehealth services for patients amid the COVID-19 pandemic to give online consultations and support sessions, including with physiotherapists and clinical psychologists. SJMC truly lives up to its reputation of being the standard-bearer for quality care in Malaysia.”
